Table 1 Patient characteristics (quantification of skin color change)

From: iTRAQ-based quantitative proteomics reveals reduced expression of KRT19, KRT7, and PTGDS in cutaneous specimens after kidney transplantation

 

Total

PEKT

Non-PEKT

P

(n = 21)

(n = 4)

(n = 17)

Age, years, median (IQR)

48

(31-57)

31.5

(18.8-50.3)

52

(32.0-65.0)

0.13

Female, n (%)

9

(42.8)

2

(50.0)

7

(41.2)

1.00

HD duration, months, median (IQR)

14

(3.5-64)

0

(0)

14

(3.5-64)

<0.01

HT

11

(52.4)

2

(50.0)

9

(52.9)

1.00

DM

1

(4.8)

0

(0)

1

(7.1)

1.00

Transplantation from Brain-dead donor

2

(9.6)

1

(25)

2

(11.8)

 

ABO blood groups (%)

      

0.33

Identical

13

(62.0)

2

(50)

11

(64.7)

 

Minor mismatch

5

(23.8)

2

(50)

3

(17.6)

 

Incompatible

3

(14.3)

0

(0)

3

(17.6)

 

Rejection, n (%)

0

(0)

0

(0)

0

(0)

1.00

BKV, n (%)

0

(0)

0

(0)

0

(0)

1.00

CMV, n (%)

10

(47.7)

3

(75)

7

(41.2)

0.31

  1. PEKT Preemptive kidney transplantation, HT Hypertension, DM Diabetes mellitus, BKV BK virus, CMV Cytomegalovirus